Skip to main content


  • Erratum
  • Open Access

Erratum to: Disease and patient characteristics in NP-C patients: findings from an international disease registry

  • 1, 8Email author,
  • 2,
  • 3,
  • 4,
  • 4,
  • 5,
  • 6 and
  • 7
Orphanet Journal of Rare Diseases20138:73

  • Received: 7 May 2013
  • Accepted: 7 May 2013
  • Published:

The original article was published in Orphanet Journal of Rare Diseases 2013 8:12


After the publication of this work [1] it was brought to the authors attention that Figure 1 contained an inversion in the color of the triangles, where yellow which should be "diagnosis" is said to be "first miglustat use", and blue which should be " first miglustat use" is said to be " diagnosis". The correct figure is given below:
Figure 1
Figure 1

Overview of patient and disease characteristics. We regret any inconvenience that this inaccuracy may have caused.



Authors’ Affiliations

Mayo Clinic, Rochester, MN, USA
Villa Metabolica, ZKJM, MC, University of Mainz, Mainz, Germany
Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
Numerus Ltd, Wokingham, UK
INSERM Unit 820, Lyon, France
Fundació Hospital Sant Joan de Déu, Barcelona, Spain
Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA


  1. Patterson MC, Eugen M, Wijburg FA, Audrey M, Barbara S, Harir D, Vanier MT, Mercé P: Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet Journal of Rare Diseases. 2013, 8: 12-10.1186/1750-1172-8-12.PubMed CentralPubMedView ArticleGoogle Scholar


© Patterson et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.